HIMS

Hims & Hers Health, Inc. NYSE Listed Sep 13, 2019

Healthcare ·Medical - Equipment & Services ·US · forhims.com

$25.56

Mkt Cap $5.6B

52w Low $13.74 20.9% of range 52w High $70.43

50d MA $22.74 200d MA $36.98

P/E (TTM) 48.1x

EV/EBITDA 52.1x

P/B 11.4x

Debt/Equity 2.3x

ROE 23.7%

P/FCF 98.8x

RSI (14) —

ATR (14) —

Beta 2.31

50d MA $22.74

200d MA $36.98

Avg Volume 39.8M

About

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 23, 2026	AMC	0.02	0.07	+250.0%	15.51	-4.4%	-0.3%	+2.0%	+0.6%	-6.4%	+6.3%	—
Nov 3, 2025	AMC	0.09	0.06	-33.3%	44.39	+3.1%	-3.6%	-1.5%	-6.5%	-7.6%	-7.5%	—
Aug 4, 2025	AMC	0.18	0.17	-5.6%	63.35	-12.7%	-12.4%	-19.3%	-19.4%	-18.0%	-21.1%	—
May 5, 2025	AMC	0.12	0.20	+65.4%	41.88	-8.5%	+18.1%	+25.0%	+22.7%	+24.1%	+31.8%	—
Feb 24, 2025	AMC	0.09	0.11	+22.2%	51.31	-22.3%	-22.3%	-18.4%	-19.4%	-12.1%	-20.7%	—
Nov 4, 2024	AMC	0.06	0.06	+0.0%	20.76	+6.4%	-0.6%	+12.8%	+13.8%	+12.8%	+34.3%	—
Aug 5, 2024	AMC	0.04	0.06	+40.5%	17.84	-1.8%	-5.4%	-10.1%	-11.2%	-10.5%	-10.5%	—
May 6, 2024	AMC	0.01	0.05	+316.7%	11.65	+17.1%	+6.0%	+4.3%	+10.9%	+5.5%	+10.6%	—
Feb 26, 2024	AMC	0.00	0.01	+151.9%	10.25	+20.3%	+31.0%	+30.0%	+27.2%	+28.0%	+43.4%	—
Nov 6, 2023	AMC	-0.03	-0.04	-27.4%	6.28	+7.8%	+11.0%	+11.8%	+5.6%	+8.4%	+11.5%	—
Aug 7, 2023	AMC	-0.05	-0.03	+40.0%	7.90	+17.2%	-5.8%	-7.3%	-9.0%	-8.9%	-9.9%	—
May 8, 2023	AMC	-0.07	-0.05	+28.6%	11.85	-9.1%	-10.1%	-9.7%	-10.8%	-8.8%	-9.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 24	JP Morgan	Initiates	Overweight	$35	$28.15	$29.50	+4.8%	+8.6%	+4.4%	-0.9%	-6.5%	-3.5%
Apr 24	BofA Securities	Maintains	Neutral → Neutral	—	$28.15	$29.50	+4.8%	+8.6%	+4.4%	-0.9%	-6.5%	-3.5%
Apr 16	BofA Securities	Maintains	Neutral → Neutral	—	$24.29	$26.15	+7.7%	+11.1%	+18.6%	+27.7%	+22.5%	+19.4%
Mar 27	TD Cowen	Maintains	Hold → Hold	—	$20.86	$20.58	-1.3%	-7.1%	-10.0%	-0.5%	-4.9%	-8.2%
Mar 16	Leerink Partners	Maintains	Market Perform → Market Perform	—	$24.77	$24.22	-2.2%	+0.4%	+0.8%	-6.5%	-2.5%	-11.1%
Mar 11	Barclays	Maintains	Overweight → Overweight	—	$23.47	$23.12	-1.5%	+10.3%	+1.6%	+5.5%	+6.0%	+6.4%
Mar 10	Deutsche Bank	Maintains	Hold → Hold	—	$22.16	$24.00	+8.3%	+5.9%	+16.8%	+7.6%	+11.8%	+12.3%
Mar 10	Citigroup	Upgrade	Sell → Neutral	—	$22.16	$24.00	+8.3%	+5.9%	+16.8%	+7.6%	+11.8%	+12.3%
Mar 10	BofA Securities	Upgrade	Underperform → Neutral	—	$22.16	$24.00	+8.3%	+5.9%	+16.8%	+7.6%	+11.8%	+12.3%
Mar 9	Needham	Upgrade	Hold → Buy	—	$15.74	$23.22	+47.5%	+40.8%	+49.1%	+64.4%	+51.5%	+57.4%
Feb 25	Barclays	Maintains	Overweight → Overweight	—	$15.46	$15.67	+1.4%	+2.3%	+0.9%	-6.1%	+6.6%	+2.3%
Feb 25	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$15.46	$15.67	+1.4%	+2.3%	+0.9%	-6.1%	+6.6%	+2.3%
Feb 24	Truist	Maintains	Hold → Hold	—	$15.51	$14.83	-4.4%	-0.3%	+2.0%	+0.6%	-6.4%	+6.3%
Feb 24	TD Cowen	Maintains	Hold → Hold	—	$15.51	$14.83	-4.4%	-0.3%	+2.0%	+0.6%	-6.4%	+6.3%
Feb 24	Leerink Partners	Maintains	Market Perform → Market Perform	—	$15.51	$14.83	-4.4%	-0.3%	+2.0%	+0.6%	-6.4%	+6.3%
Feb 24	Evercore ISI	Maintains	In Line → In Line	—	$15.51	$14.83	-4.4%	-0.3%	+2.0%	+0.6%	-6.4%	+6.3%
Feb 24	Citigroup	Maintains	Sell → Sell	—	$15.51	$14.83	-4.4%	-0.3%	+2.0%	+0.6%	-6.4%	+6.3%
Feb 24	BTIG	Downgrade	Buy → Neutral	—	$15.51	$14.83	-4.4%	-0.3%	+2.0%	+0.6%	-6.4%	+6.3%
Feb 9	TD Cowen	Maintains	Hold → Hold	—	$23.02	$17.83	-22.5%	-16.0%	-25.1%	-27.5%	-31.4%	-29.2%
Feb 9	Citigroup	Maintains	Sell → Sell	—	$23.02	$17.83	-22.5%	-16.0%	-25.1%	-27.5%	-31.4%	-29.2%
Feb 9	BofA Securities	Maintains	Underperform → Underperform	—	$23.02	$17.83	-22.5%	-16.0%	-25.1%	-27.5%	-31.4%	-29.2%
Feb 2	BTIG	Maintains	Buy → Buy	—	$27.09	$27.11	+0.1%	-2.4%	-5.7%	-9.9%	-13.3%	-15.0%
Nov 4	BofA Securities	Maintains	Underperform → Underperform	—	$44.39	$45.75	+3.1%	-3.6%	-1.5%	-6.5%	-7.6%	-7.5%
Nov 4	BTIG	Maintains	Buy → Buy	—	$44.39	$45.75	+3.1%	-3.6%	-1.5%	-6.5%	-7.6%	-7.5%
Sep 12	Canaccord Genuity	Maintains	Buy → Buy	—	$51.76	$51.03	-1.4%	+7.2%	+4.3%	-1.7%	-2.7%	+8.6%
Aug 18	Truist	Maintains	Hold → Hold	—	$46.02	$45.22	-1.7%	-2.0%	-8.3%	-5.7%	-4.5%	-3.2%
Aug 5	Needham	Maintains	Hold → Hold	—	$63.35	$55.30	-12.7%	-12.4%	-19.3%	-19.4%	-18.0%	-21.1%
Jul 17	Truist	Maintains	Hold → Hold	—	$51.85	$51.72	-0.3%	-3.6%	-2.8%	-8.2%	-3.5%	+11.9%
Jun 11	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$55.25	$54.68	-1.0%	+4.2%	+3.4%	+0.4%	+8.2%	+7.2%
Jun 4	Needham	Maintains	Buy → Buy	—	$54.73	$55.77	+1.9%	-2.0%	-3.6%	+2.9%	+3.9%	+1.0%
May 6	Piper Sandler	Maintains	Neutral → Neutral	—	$41.88	$38.33	-8.5%	+18.1%	+25.0%	+22.7%	+24.1%	+31.8%
May 6	Citigroup	Maintains	Sell → Sell	—	$41.88	$38.33	-8.5%	+18.1%	+25.0%	+22.7%	+24.1%	+31.8%
May 6	Needham	Maintains	Buy → Buy	—	$41.88	$38.33	-8.5%	+18.1%	+25.0%	+22.7%	+24.1%	+31.8%
Apr 29	BofA Securities	Maintains	Underperform → Underperform	—	$28.48	$37.94	+33.2%	+23.0%	+16.2%	+27.0%	+43.3%	+47.1%
Apr 29	TD Cowen	Downgrade	Buy → Hold	—	$28.48	$37.94	+33.2%	+23.0%	+16.2%	+27.0%	+43.3%	+47.1%
Apr 29	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$28.48	$37.94	+33.2%	+23.0%	+16.2%	+27.0%	+43.3%	+47.1%
Apr 25	Citigroup	Maintains	Sell → Sell	—	$28.14	$27.86	-1.0%	-0.2%	+1.2%	+24.5%	+17.6%	+28.5%
Apr 10	Truist	Maintains	Hold → Hold	—	$29.49	$28.49	-3.4%	-9.1%	-7.7%	-4.0%	-0.1%	-8.6%
Mar 18	BofA Securities	Maintains	Underperform → Underperform	—	$34.69	$34.31	-1.1%	-9.2%	-2.3%	-5.2%	+0.2%	+7.8%
Mar 6	Citigroup	Maintains	Sell → Sell	—	$40.89	$37.40	-8.5%	-15.9%	-12.1%	-15.7%	-15.1%	-17.0%
Mar 6	BofA Securities	Maintains	Underperform → Underperform	—	$40.89	$37.40	-8.5%	-15.9%	-12.1%	-15.7%	-15.1%	-17.0%
Feb 26	Truist	Maintains	Hold → Hold	—	$39.86	$40.24	+1.0%	+5.1%	+3.7%	+13.1%	+2.1%	+1.6%
Feb 25	Piper Sandler	Maintains	Neutral → Neutral	—	$51.31	$39.88	-22.3%	-22.3%	-18.4%	-19.4%	-12.1%	-20.7%
Feb 25	Citigroup	Maintains	Sell → Sell	—	$51.31	$39.88	-22.3%	-22.3%	-18.4%	-19.4%	-12.1%	-20.7%
Feb 25	Needham	Maintains	Buy → Buy	—	$51.31	$39.88	-22.3%	-22.3%	-18.4%	-19.4%	-12.1%	-20.7%
Feb 25	Leerink Partners	Maintains	Market Perform → Market Perform	—	$51.31	$39.88	-22.3%	-22.3%	-18.4%	-19.4%	-12.1%	-20.7%
Feb 20	BofA Securities	Maintains	Underperform → Underperform	—	$68.74	$65.08	-5.3%	-3.4%	-28.3%	-25.4%	-42.0%	-39.1%
Feb 19	Canaccord Genuity	Maintains	Buy → Buy	—	$58.50	$59.26	+1.3%	+17.5%	+13.5%	-15.8%	-12.3%	-31.9%
Feb 18	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$60.47	$60.70	+0.4%	-3.3%	+13.7%	+9.8%	-18.5%	-15.1%
Jan 10	Citigroup	Downgrade	Neutral → Sell	—	$25.73	$24.15	-6.1%	-1.2%	+0.7%	+1.9%	+8.3%	+8.6%

Recent Filings

8-K · 7.01 ! Medium

Unknown — 8-K 7.01: Regulation FD Disclosure

Hims secured a strategic Novo Nordisk partnership to expand GLP-1 weight-loss offerings, positioning it competitively in the booming telehealth obesity market and diversifying beyond single-drug dependency.

Mar 11

8-K

Hims & Hers Health, Inc. -- 8-K Filing

Hims & Hers reported fourth quarter and full year 2025 financial results, with CFO Oluyemi Okupe as principal financial officer; detailed results available in shareholder letter.

Feb 23

8-K · 1.01 !! High

Hims & Hers Health, Inc. -- 8-K 1.01: Material Agreement

Hims & Hers is expanding internationally through a strategic acquisition of an Australia-based digital health operator with established presence in five countries, strengthening its global telehealth footprint.

Feb 19

Data updated apr 25, 2026 1:28pm · Source: massive.com